Vimarsana
Biggest News Aggregation in the World

Page 6 - Timothyc Dec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Timothyc Dec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Timothyc Dec Today - Breaking & Trending Today

Supernus to Present at the 2022 Wells Fargo Healthcare Conference - Vimarsana News

Supernus to Present at the 2022 Wells Fargo Healthcare Conference

ROCKVILLE, Md., Aug. 31, 2022 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ... | August 31, 2022

Supernus to Participate in the Jefferies Healthcare Conference - Vimarsana News

Supernus to Participate in the Jefferies Healthcare Conference

ROCKVILLE, Md., June 02, 2022 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ... | June 2, 2022

Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults - Vimarsana News

Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults

First novel, nonstimulant option for adults with ADHD in 20 years ADHD affects an estimated 10 million adults in the U.S.ROCKVILLE, Md., May 2, 20...

Supernus Announces FDA Approval of Qelbree® for the - Vimarsana News

Supernus Announces FDA Approval of Qelbree® for the

First novel, nonstimulant option for adults with ADHD in 20 yearsADHD affects an estimated 10 million adults in the U.S. ROCKVILLE, Md., April 29, 2022 ...

Supernus Pharmaceuticals Targeted in Ransomware Incident - Vimarsana News

Supernus Pharmaceuticals Targeted in Ransomware Incident

25.11.2021 - The attack had no significant impact on the business and did not cause any significant disruption to Company’s operations No ransom payments have been made by the Company ROCKVILLE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) - Supernus Pharmaceuticals, ...